Bulletin
Investor Alert

Company Close Updates

Jan. 19, 2022, 4:32 p.m. EST

Johnson & Johnson stock underperforms Wednesday when compared to competitors

MarketWatch Automation

Shares of Johnson & Johnson (NYS:JNJ) shed 0.31% to $166.58 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index (S&P:SPX) falling 0.97% to 4,532.76 and Dow Jones Industrial Average (DOW:DJIA) falling 0.96% to 35,028.65. This was the stock's seventh consecutive day of losses. Johnson & Johnson closed $13.34 short of its 52-week high ($179.92), which the company achieved on August 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. (OTC:RHHVF) rose 0.82% to $398.68, Merck & Co. Inc. (NYS:MRK) fell 0.31% to $81.29, and Pfizer Inc. (NYS:PFE) fell 1.05% to $53.54. Trading volume (5.9 M) remained 1.6 million below its 50-day average volume of 7.5 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.